We are live on ! Find out more
MAA

Matrix Asset Advisors Portfolio holdings

AUM $1.23B
1-Year Est. Return 26.4%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+26.4%
3 Year Est. Return
+76.91%
5 Year Est. Return
+80.77%
10 Year Est. Return
+258.88%
AUM
$630M
AUM Growth
+$23.1M
Cap. Flow
-$11M
Cap. Flow %
-1.74%
Top 10 Hldgs %
38.93%
Holding
71
New
3
Increased
22
Reduced
37
Closed
4

Sector Composition

1 Financials 23.8%
2 Healthcare 16.85%
3 Technology 15.81%
4 Energy 12.35%
5 Consumer Staples 11.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$907B
$32.5M 5.15%
303,568
-9,535
-3% -$965K
MSFT icon
2
Microsoft
MSFT
$2.93T
$29.3M 4.65%
342,316
-8,483
-2% -$696K
WFC icon
3
Wells Fargo
WFC
$265B
$28.5M 4.53%
470,471
-8,421
-2% -$476K
ETN icon
4
Eaton
ETN
$155B
$24.7M 3.92%
312,549
-2,119
-0.7% -$165K
ABBV icon
5
AbbVie
ABBV
$450B
$24.5M 3.89%
253,472
-7,445
-3% -$702K
CSCO icon
6
Cisco
CSCO
$441B
$24M 3.8%
625,460
-16,746
-3% -$598K
MET icon
7
MetLife
MET
$60.5B
$21.7M 3.44%
429,094
-7,517
-2% -$396K
QCOM icon
8
Qualcomm
QCOM
$181B
$20.7M 3.29%
323,957
+8,444
+3% +$512K
RTX icon
9
RTX Corp
RTX
$261B
$19.9M 3.17%
248,491
-5,206
-2% -$395K
PG icon
10
Procter & Gamble
PG
$349B
$19.5M 3.1%
212,330
-259
-0.1% -$23.3K
PEP icon
11
PepsiCo
PEP
$187B
$17.7M 2.8%
147,200
-262
-0.2% -$29.9K
GILD icon
12
Gilead Sciences
GILD
$167B
$17.2M 2.73%
239,715
+16,178
+7% +$1.23M
CVX icon
13
Chevron
CVX
$373B
$16.2M 2.58%
129,662
-16,249
-11% -$1.93M
TFC icon
14
Truist Financial
TFC
$65.4B
$16.1M 2.55%
323,731
-4,067
-1% -$196K
OXY icon
15
Occidental Petroleum
OXY
$54.6B
$16M 2.55%
217,879
-5,985
-3% -$406K
TEL icon
16
TE Connectivity
TEL
$59.3B
$15.9M 2.52%
167,371
-8,741
-5% -$804K
GOOG icon
17
Alphabet (Google) Class C
GOOG
$4.22T
$14.5M 2.31%
278,060
-7,300
-3% -$372K
ZBH icon
18
Zimmer Biomet
ZBH
$17.6B
$13.9M 2.21%
118,990
+3,264
+3% +$369K
SLB icon
19
SLB Ltd
SLB
$70.3B
$12.9M 2.04%
190,822
+37,983
+25% +$2.46M
COF icon
20
Capital One
COF
$128B
$12.7M 2.01%
127,331
-3,821
-3% -$349K
TMO icon
21
Thermo Fisher Scientific
TMO
$198B
$12.3M 1.95%
64,640
-2,428
-4% -$465K
CB icon
22
Chubb
CB
$137B
$12.1M 1.93%
83,128
-3,197
-4% -$478K
CVS icon
23
CVS Health
CVS
$137B
$11.2M 1.78%
154,821
-109,689
-41% -$7.97M
JCI icon
24
Johnson Controls International
JCI
$85.7B
$10.8M 1.72%
283,753
-15,238
-5% -$595K
UPS icon
25
United Parcel Service
UPS
$100B
$10.3M 1.63%
86,290
+1,622
+2% +$191K

Similar funds

Matrix Asset Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Matrix Asset Advisors held 71 positions worth $630M, up 3.8% from $607M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Matrix Asset Advisors's Q4 2017 filing shows 3 new, 22 increased, 37 reduced and 4 closed positions. Its largest new stake was Paramount Global Class B: 48,397 shares worth $2.85M. The largest sale was CVS Health, an estimated $7.97M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

  • Matrix Asset Advisors's largest Q4 2017 buy was Paramount Global Class B: 48,397 shares worth $2.85M.
  • Matrix Asset Advisors added most to Mondelez International in Q4 2017, an estimated $3.84M increase.
  • Matrix Asset Advisors's biggest Q4 2017 reduction was CVS Health, cutting an estimated $7.97M.
  • Matrix Asset Advisors fully exited SITE Centers in Q4 2017, selling an estimated $220K.
  • Matrix Asset Advisors's ten largest holdings make up 39% of its $630M portfolio in Q4 2017.
  • Matrix Asset Advisors opened 3 new positions and closed 4 in Q4 2017.
  • Matrix Asset Advisors's portfolio value rose 3.8% quarter-over-quarter to $630M.

Based on Matrix Asset Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.